GlassScriptPhysician profile
Yolanda Negrete
NPI 1720733116
$4,414.55
in general payments reported to CMS, 2019-2025
23 companies · $1,856 in 2025
The $1,856 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $46.17 · 2023: $257 · 2024: $2,255 · 2025: $1,856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,973 · Travel and Lodging: $330 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,973.04 |
| Travel and Lodging | $330.35 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $978.84 | 2023-2025 | Tezspire, Breztri, Airsupra |
| Inspire Medical Systems, INC. | $622.18 | 2024 | Inspire |
| Actelion Pharmaceuticals US, INC. | $406.73 | 2024-2025 | Uptravi, Opsumit |
| Glaxosmithkline, LLC. | $369.42 | 2024-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Mylan Specialty L.P. | $342.85 | 2023-2024 | Yupelri |
| Viatris Specialty LLC | $281.78 | 2025 | Yupelri |
| Lilly USA, LLC | $218.42 | 2022-2025 | Zepbound, Mounjaro, Trulicity |
| Insmed, INC. | $208.24 | 2025 | Arikayce |
| Electromed, INC. | $166.03 | 2024-2025 | Smartvest |
| United Therapeutics Corporation | $137.18 | 2025 | Tyvaso, Tyvaso |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.38 | 2024-2025 | Ofev, Jascayd |
| Verona Pharma, INC. | $97.92 | 2025 | Ohtuvayre |
| Philips North America LLC | $96.86 | 2024-2025 | Respiratory, Home Pi Undivided, (O58) Sleep Respiratory Care Und |
| Janssen Pharmaceuticals, INC | $67.27 | 2023-2024 | Xarelto |
| Baxter Healthcare | $65.90 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $56.06 | 2023 | Nuzyra |
| Merck Sharp & Dohme LLC | $55.86 | 2024 | Keytruda |
| E.R. Squibb & Sons, L.L.C. | $32.83 | 2023 | Eliquis |
| Genzyme Corporation | $28.68 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.03 | 2025 | Glassia |
| Exact Sciences Corporation | $20.13 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $18.81 | 2023 | |
| Novo Nordisk INC | $16.15 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yolanda Negrete listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.